Cargando…
Lysophosphatidic Acid: Promoter of Cancer Progression and of Tumor Microenvironment Development. A Promising Target for Anticancer Therapies?
Increased expression of the enzyme autotaxin (ATX) and the consequently increased levels of its product, lysophosphatidic acid (LPA), have been reported in several primary tumors. The role of LPA as a direct modulator of tumor cell functions—motility, invasion and migration capabilities as well as r...
Autores principales: | Aiello, Sistiana, Casiraghi, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229068/ https://www.ncbi.nlm.nih.gov/pubmed/34200030 http://dx.doi.org/10.3390/cells10061390 |
Ejemplares similares
-
Promising Pharmacological Directions in the World of Lysophosphatidic Acid Signaling
por: Stoddard, Nicole C., et al.
Publicado: (2015) -
Lysophosphatidic Acid Receptor Signaling in the Human Breast Cancer Tumor Microenvironment Elicits Receptor-Dependent Effects on Tumor Progression
por: Benesch, Matthew G. K., et al.
Publicado: (2023) -
Lysophosphatidic acid in carcinogenesis and tumor development
por: Albrecht, Wiebke
Publicado: (2018) -
Lysophosphatidic Acid Analogue rather than Lysophosphatidic Acid Promoted the Bone Formation In Vivo
por: Yu, Zi-Li, et al.
Publicado: (2018) -
Lysophosphatidic acid-RAGE axis promotes lung and mammary oncogenesis via protein kinase B and regulating tumor microenvironment
por: Ray, Rashmi, et al.
Publicado: (2020)